Funder
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Publisher
Springer Science and Business Media LLC
Reference88 articles.
1. Inrig JK, Califf RM, Tasneem A, Vegunta RK, Molina C, Stanifer JW, et al. The landscape of clinical trials in nephrology: a systematic review of Clinicaltrials.gov. Am J Kidney Dis. 2014 May;63(5):771-80. PubMed PMID: 24315119. Pubmed Central PMCID: PMC3988265. Epub 2013/12/10.
2. Baigent C, Herrington WG, Coresh J, Landray MJ, Levin A, Perkovic V, et al. Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2017 Aug;92(2):297–305. PubMed PMID: 28709600. Pubmed Central PMCID: PMC6326036. Epub 2017/07/16.
3. Suki WN, Zabaneh R, Cangiano JL, Reed J, Fischer D, Garrett L, et al. Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Kidney Int. 2007 Nov;72(9):1130–7. PubMed PMID: 17728707. Epub 2007/08/31.
4. Investigators ET, Chertow GM, Block GA, Correa-Rotter R, Drueke TB, Floege J, et al. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med. 2012 Dec 27;367(26):2482–94. PubMed PMID: 23121374. Epub 2012/11/06.
5. Parfrey PS, Block GA, Correa-Rotter R, Drueke TB, Floege J, Herzog CA, et al. Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on Dialysis. Clin J Am Soc Nephrol. 2016 Mar 7;11(3):539–46. PubMed PMID: 26614406. Pubmed Central PMCID: PMC4791832. Epub 2015/11/29.